EFFICACY AND SAFETY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN INCONTINENT OAB SUBJECTS WITH AN INADEQUATE RESPONSE TO INITIAL 4-WEEK SOLIFENACIN MONOTHERAPY

被引：2
|
作者：
Drake, Marcus
Esen, Ahmet Adil
Athanasiou, Stavros
Herholdt, Claire
Saleem, Tahir
Huang, Moses
Siddiqui, Emad
Baronio, Roberta
MacDiarmid, Scott
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
solifenacin; mirabegron; overactive bladder;
D O I：
10.1016/j.juro.2015.03.118
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PII-LBA9
引用
收藏
页码：E498 / E499
页数：2
相关论文
共 27 条
  • [1] SAFETY AND EFFICACY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN INCONTINENT OAB SUBJECTS WITH AN INADEQUATE RESPONSE TO INITIAL 4-WEEK SOLIFENACIN MONOTHERAPY
    Drake, M.
    Esen, Adil A.
    Athanasiou, S.
    Herholdt, C.
    Kaper, M.
    Saleem, T.
    Huang, M.
    Siddiqui, E.
    MacDiarmid, S.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S401 - S402
  • [2] EFFICACY AND SAFETY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN INCONTINENT OVER ACTIVE BLADDER (OAB) PATIENTS WITH AN INADEQUATE RESPONSE TO INITIAL 4-WEEK SOLIFENACIN TREATMENT
    Drake, Marcus J.
    Esen, Ahmet Adil
    Athanasiou, Stavros
    Herholdt, Claire
    Kaper, Mathilde
    Saleem, Tahir
    Huang, Moses
    Siddiqui, Emad
    MacDiarmid, Scott
    [J]. NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S107 - S108
  • [3] Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy
    MacDiarmid, Scott
    Al-Shukri, Salman
    Barkin, Jack
    Fianu-Jonasson, Aino
    Grise, Philippe
    Herschorn, Sender
    Saleem, Tahir
    Huang, Moses
    Siddiqui, Emad
    Stolzel, Matthias
    Hemsted, Claire
    Nazir, Jameel
    Hakimi, Zalmai
    Drake, Marcus J.
    [J]. JOURNAL OF UROLOGY, 2016, 196 (03): : 809 - 818
  • [4] Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy EDITORIAL COMMENT
    Chughtai, Bilal
    [J]. JOURNAL OF UROLOGY, 2016, 196 (03): : 818 - 818
  • [5] Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
    Drake, Marcus J.
    Chapple, Christopher
    Esen, Ahmet A.
    Athanasiou, Stavros
    Cambronero, Javier
    Mitcheson, David
    Herschorn, Sender
    Saleem, Tahir
    Huang, Moses
    Siddiqui, Emad
    Stolzel, Matthias
    Herholdt, Claire
    MacDiarmid, Scott
    [J]. EUROPEAN UROLOGY, 2016, 70 (01) : 136 - 145
  • [6] Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
    Cruz, Francisco
    [J]. EUROPEAN UROLOGY, 2016, 70 (05) : 892 - 892
  • [7] Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-Blind Multicentre Phase 3B Study ( BESIDE)
    Wein, Alan J.
    [J]. JOURNAL OF UROLOGY, 2017, 197 (03): : 767 - 768
  • [8] SAFETY AND EFFICACY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN OAB SUBJECTS IN COMPARISON TO SOLIFENCIN MONOTHERAPY: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Naser, O.
    Elgebaly, A.
    Menshawy, A.
    Kamal, Y.
    Negida, A.
    Gana, B.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S206 - S207
  • [9] POST-VOID RESIDUAL (PVR) VOLUME AND URINARY RETENTION ASSESSMENTS IN A RANDOMIZED, DOUBLE-BLIND, PHASE IIIB TRIAL OF MIRABEGRON ADD-ON TREATMENT IN INCONTINENT OVERACTIVE BLADDER (OAB) PATIENTS WITH AN INADEQUATE RESPONSE TO 4-WEEK SOLIFENACIN MONOTHERAPY (BESIDE)
    Drake, M.
    MacDiarmid, S.
    Al-Shukri, S.
    Barkin, J.
    Fianu-Jonasson, A.
    Grise, P.
    Herschorn, S.
    Huang, M.
    Stolzel, M.
    Hemsted, C.
    Siddiqui, E.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S295 - S296
  • [10] Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)
    Drake, Marcus J.
    MacDiarmid, Scott
    Chapple, Christopher R.
    Esen, Adil
    Athanasiou, Stavros
    Cambronero Santos, Javier
    Mitcheson, David
    Herschorn, Sender
    Siddiqui, Emad
    Huang, Moses
    Stoelzel, Matthias
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
123